Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.54 | €3.70 | 140.885% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €121.40 | €124.93 | 2.907% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.55 | €23.46 | 61.264% |
| Drägerwerk AG & Co. KGaA ST | 2 | 0 | 0 | 0 | €44.70 | - | - |
| Medtronic plc | 9 | 1 | 0 | 0 | €76.61 | €93.46 | 21.988% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €205.70 | €204.50 | -0.583% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €38.79 | €48.50 | 25.032% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| Bastide Le Confort | 1 | 0 | 1 | 0 | €19.46 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.80 | €4.00 | 42.857% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.73 | €4.39 | 153.686% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.63 | €116.81 | 19.643% |
| UCB S.A. | 2 | 0 | 0 | 0 | €118.80 | - | - |
| Cigna Corp. | 17 | 0 | 3 | 0 | €324.15 | €342.35 | 5.615% |
| Vertex Pharmaceuticals Inc. | 44 | 2 | 8 | 0 | €389.95 | €404.41 | 3.707% |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.78 | €35.99 | 25.036% |
| Myriad Genetics | 6 | 2 | 1 | 0 | €22.00 | €24.18 | 9.913% |
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | €96.00 | €109.94 | 14.525% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.06 | €26.95 | 168.023% |
| Edwards Lifesciences Corp. | 26 | 1 | 4 | 0 | €81.81 | €88.15 | 7.754% |
| GSK plc | 1 | 0 | 0 | 0 | €20.64 | - | - |
| Patterson Companies Inc. | 6 | 0 | 0 | 0 | €23.80 | €32.18 | 35.219% |